Preventive eye care products for summer heat season
The Opportunity
Indore and similar regions experience early summer heat waves with temperatures reaching 36-38°C, causing a spike in eye-related complaints including irritation, dryness, redness, and allergic conjunctivitis. Doctors report increased cases during dry, dusty periods, but there is no specialized product line addressing this seasonal demand surge.
Market Size
₹850-1,200 crore annual Indian eye care market; summer segment represents 15-20% of annual ophthalmic product sales (₹130-240 crore). Indore district alone has 40 lakh residents with seasonal eye issues affecting 8-12% during peak summer.
Business Model
Manufacture and distribute a branded seasonal eye care product line (preservative-free lubricating drops, cooling eye gels, UV-protective sunglasses, dust-blocking eye shields) through pharmacies, clinics, and direct-to-consumer channels in heat-prone Indian cities.
1) Direct pharmacy sales of eye drops (₹80-120 per unit, 50,000 units/month = ₹40-60 lakh/month during peak season). 2) B2B supply to clinics and hospitals (bulk discounts, ₹25-30 lakh/quarter). 3) Seasonal e-commerce bundles and subscription boxes (₹15-20 lakh/season).
Your 30-Day Action Plan
Research Indian pharmaceutical eye drop manufacturers offering contract manufacturing; identify 3-4 partners with FSSAI and ISO certification. Obtain sample formulations for preservative-free lubricating drops.
File application with state drug authority (Madhya Pradesh) for manufacturing license or obtain permission for repackaging existing approved formulations. Engage regulatory consultant (₹30-50k).
Design product packaging with SPF/UV protection claims; conduct 50-person focus group test in Indore clinics to validate seasonal demand and price sensitivity (₹20k budget).
Establish partnerships with 5-10 leading pharmacy chains in Indore and neighboring cities (Khandwa benefits from new NH-347BG highway access). Pre-order initial 10,000 units from manufacturer.
Compliance & Regulatory Angle
Manufacturing license under Drugs and Cosmetics Act 1940; eye drops classified as OTC drugs requiring FSSAI approval and bioavailability testing. GST rate 5% for pharmaceutical products. Product must comply with Bureau of Indian Standards (BIS) for optical aids if bundling sunglasses. No import duty if manufactured in India; 10% if importing finished goods.
Ready to Act on This Opportunity?
Generate a 7-step execution plan — validate the market, build the MVP, model the financials, map the risks, and ship in 30 days.